Christopher J. Twomey's most recent trade in Bionano Genomics Inc was a trade of 2,775 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 2,775 | 2,775 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 8,759 | 8,759 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.64 per share. | 21 May 2025 | 4,387 | 15,675 (0%) | 0% | 20.6 | 90,548 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 4,387 | 0 | - | - | Restricted Stock Unit | |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 4,434 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.73 per share. | 22 May 2024 | 4,434 | 11,288 (0%) | 0% | 51.7 | 229,371 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,387 | 4,387 | - | - | Restricted Stock Unit | |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 4,434 | 4,434 | - | - | RSU 2023 05 24 | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 2,757 | 6,854 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 164,422 | 164,422 | - | - | Stock Option (right to buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,205 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 2,205 | 4,097 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2022 | 238 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 05 May 2022 | 238 | 5,270 (0%) | 0% | 73.7 | 17,547 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 111.73 per share. | 05 May 2022 | 158 | 5,112 (0%) | 0% | 111.7 | 17,653 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 05 May 2022 | 135 | 7,658 (0%) | 0% | 73.7 | 9,953 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2022 | 135 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 111.73 per share. | 05 May 2022 | 90 | 7,568 (0%) | 0% | 111.7 | 10,056 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 129.09 per share. | 07 Sep 2021 | 2,500 | 5,032 (0%) | 0% | 129.1 | 322,713 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 123.00 per share. | 07 Sep 2021 | 304 | 7,532 (0%) | 0% | 123 | 37,392 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 115.01 per share. | 02 Sep 2021 | 4,696 | 7,836 (0%) | 0% | 115.0 | 540,077 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 02 Sep 2021 | 4,000 | 7,523 (0%) | 0% | 115 | 460,000 | Common Stock |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 40,751 | 40,751 | - | - | Stock Option (right to buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 29 Jul 2021 | 5,000 | 15,032 (0%) | 0% | 105 | 525,000 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 29 Jul 2021 | 3,000 | 11,523 (0%) | 0% | 105 | 315,000 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 104.89 per share. | 29 Jul 2021 | 2,500 | 12,532 (0%) | 0% | 104.9 | 262,213 | Common Stock |
| Bionano Genomics Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 7,528 | 7,528 | - | - | Stock Option (right to buy) | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 1,892 | 1,892 (0%) | 0% | 0 | Common Stock | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 1,892 | 0 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,205 | 2,205 | - | - | Restricted Stock Unit | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 189 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.72 per share. | 18 May 2021 | 189 | 20,189 (0%) | 0% | 73.7 | 13,934 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 89.03 per share. | 18 May 2021 | 157 | 20,032 (0%) | 0% | 89.0 | 13,978 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 18 May 2021 | 135 | 14,635 (0%) | 0% | 73.7 | 9,953 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 135 | 0 | - | - | Warrant | |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 89.03 per share. | 18 May 2021 | 112 | 14,523 (0%) | 0% | 89.0 | 9,971 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 21 Apr 2021 | 3,401 | 22,500 (0%) | 0% | 95 | 323,095 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Gift of securities by or to the insider at price $ 93.64 per share. | 21 Apr 2021 | 2,500 | 20,000 (0%) | 0% | 93.6 | 234,088 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.02 per share. | 21 Apr 2021 | 1,599 | 15,901 (0%) | 0% | 95.0 | 151,934 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.02 per share. | 21 Apr 2021 | 1,599 | 25,901 (0%) | 0% | 95.0 | 151,934 | Common Stock |
| Tandem Diabetes Care Inc | Christopher J. Twomey | Director | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 21 Apr 2021 | 1,401 | 14,500 (0%) | 0% | 95 | 133,095 | Common Stock |